Snapshot
Continue to About ↓- What it does
- Enzyme Onyx is a white-label tech stack that lets businesses and institutions issue, structure and administer tokenized funds and financial instruments on-chain, including back-office accounting, NAV reporting, deposits/redemptions and investor services.
More detail
- It is part of the broader Enzyme suite, which also includes the Blue vault-management platform and the Myso on-chain options protocol.
- Best for
- Fund platforms, asset managers, issuers, administrators, custodians, brokers, neobanks and exchanges that want to launch and operate tokenized funds or instruments without building middle- and back-office infrastructure themselves.
- Pricing
- Enzyme markets Onyx with a "View Pricing" path and references an "Incremental" Vault-as-a-Service tier carrying a $6,000 annual minimum, but the full fee schedule, spreads, transaction costs and any lockups or withdrawal conditions are not fully disclosed in the reviewed pages.
More detail
- Treat exact total cos
- Main limitation
- Retail or consumer users seeking a self-serve product, and teams on non-EVM or unlisted networks, since Onyx is described as natively available on EVM networks, Rayls and Canton.
- Record
- Living and monitored
- Reviewed
- Evidence
- Public web research
- Machine access
- Structured profile ↗
About
- Enzyme Onyx is a white-label tech stack that lets businesses and institutions issue, structure and administer tokenized funds and financial instruments on-chain, including back-office accounting, NAV reporting, deposits/redemptions and investor services.
- It is part of the broader Enzyme suite, which also includes the Blue vault-management platform and the Myso on-chain options protocol.
What it helps with
- Launching a tokenized fund traditionally requires building middle- and back-office infrastructure from scratch.
- Fund managers need programmable fee logic (management, performance, entry and exit fees) without custom development.
- Investors require queued or real-time deposits and redemptions across multiple assets and chains.
- Regulated issuers need accounting, NAV reporting and investor registry controls that fit compliance frameworks such as M
- Distributing a tokenized product through partners requires a white-label interface and embeddable APIs.
- Managing decentralized strategies across many protocols and assets is operationally fragmented.
Capabilities
A practical view of what is available and where limitations apply.
| Offering | Available | Detail |
|---|---|---|
| Tokenization engine | Yes | Issue tokenized funds and instruments with custom ERC-20 instrument tokens and custom tickers. |
| Programmable fee engine | Yes | Management, performance, entry and exit fees with accrual, high-water mark, hurdle rate and unlimited fee recipients. |
| Deposits and redemptions | Yes | Queued or synchronous deposits, queued redemptions, cross-chain deposits and share minting; ERC-7520 and ERC-4636 compatibility. |
| NAV and accounting | Yes | Built-in NAV calculation and manual, semi-automated or automated portfolio reporting, with Chainlink Runtime Environment integration for automated on-chain NAV. |
| Investor services and compliance | Limited | On-chain registry compatible with KYC/KYB solutions, allowlists and transferability controls; Enzyme describes itself as compliance-ready but does not claim to hold licenses on your behalf. |
| White-label investor interface | Yes | Embed tokenized products into your own interface via modular architecture and open APIs. |
| Multi-chain availability | Limited | Onyx is stated as natively available on EVM networks, Rayls and Canton; non-EVM or unlisted networks are not supported per reviewed pages. |
| DeFi strategy management (Blue) | Yes | Part of the wider Enzyme suite: 30+ protocols, 200+ assets, delegation, analytics and automation. |
| On-chain options (Myso) | Yes | Part of the wider Enzyme suite: covered calls and cash-secured puts with RFQ, instant match and Dutch auction settlement. |
| Transparent published pricing | Unknown | A $6,000 annual minimum is referenced for one VaaS tier, but the complete fee schedule and total cost are not fully disclosed in the reviewed pages. |
Bot trust
How confidently AI systems can verify this profile from public evidence.
—of 100
ChatGPT—/100
Claude—/100
This profile has not completed a Bot Score assessment yet.
Evidence
Where this record came from, when it was reviewed, and how confidently it can be used.
- Verification
- Scribble researched these facts from the linked public sources.
- The owner has not manually confirmed every field.
- Last reviewed
- Primary source
- enzyme.finance
Technical profile details
Record ID
1e4ebf48-4369-4a38-959e-2ca0a01b6d5fCanonical URLhttps://profiles.scribble.network/listing/enzyme-onyx-1e4ebf48